Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hans A. de Haan"'
Autor:
Johanna C. Bendell, John Nemunaitis, George R. Blumenschein, Heather Raymon, Amit Mahipal, Barbara Eichhorst, Christophe Massard, David Smith, Pamela N. Munster, Hans A. de Haan, Timothy F. Cloughesy, Dana E. Rathkopf, Monica M. Mita, Cristina Cruz, Luis Paz-Ares, Tom Mikkelsen, Shaoyi Li, Kristen Hege, Manuel Hidalgo, Ellen Filvaroff
Publikováno v:
Cancer Management and Research. 11:10463-10476
Author(s): Munster, Pamela; Mita, Monica; Mahipal, Amit; Nemunaitis, John; Massard, Christophe; Mikkelsen, Tom; Cruz, Cristina; Paz-Ares, Luis; Hidalgo, Manuel; Rathkopf, Dana; Blumenschein, George; Smith, David C; Eichhorst, Barbara; Cloughesy, Tim;
Autor:
John Nemunaitis, Luis Paz-Ares, Amit Mahipal, Shaoyi Li, Pamela N. Munster, Tim Meyer, Hans A. de Haan, Kristen Hege, Monica M. Mita, Johanna C. Bendell, Edward M. Wolin, Ellen Filvaroff, Alain C. Mita
Publikováno v:
PLoS ONE
PloS one, vol 14, iss 9
Repisalud
Instituto de Salud Carlos III (ISCIII)
PLoS ONE, Vol 14, Iss 9, p e0221994 (2019)
PloS one, vol 14, iss 9
Repisalud
Instituto de Salud Carlos III (ISCIII)
PLoS ONE, Vol 14, Iss 9, p e0221994 (2019)
Second-generation mammalian target of rapamycin (mTOR) inhibitors such as CC-223 may have theoretical advantages over first-generation drugs by inhibiting TOR kinase in mTOR complex 1 (mTORC1) and 2 (mTORC2), potentially improving clinical efficacy f
Publikováno v:
Human Gene Therapy. 23:91-97
Oncolytic virotherapy poses unique challenges to the evaluation of tumor response. We hypothesized that the addition of [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) to standard computed tomography (CT) evaluation would improve d
Autor:
Anette Knoll, Daniel Y. Sze, Axel Mescheder, David A. Geller, Kenneth K. Tanabe, Tony R. Reid, Hans A. de Haan, Sunil K. Geevarghese, John Nemunaitis, Markus Hörer, Hoda Tawfik
Publikováno v:
Human Gene Therapy. 21:1119-1128
This multicenter phase I/II study evaluated the safety, pharmacokinetics, and antitumor effects of repeated doses of NV1020, a genetically engineered oncolytic herpes simplex virus, in patients with advanced metastatic colorectal cancer (mCRC). Patie
Autor:
Hans A. de Haan
Publikováno v:
International Journal of Pharmaceutical Medicine. 16:39
Publikováno v:
Human Gene Therapy; Jan2012, Vol. 23 Issue 1, p91-97, 7p
Autor:
Sunil K. Geevarghese, David A. Geller, Hans A. de Haan, Markus Hörer, Anette E. Knoll, Axel Mescheder, John Nemunaitis, Tony R. Reid, Daniel Y. Sze, Kenneth K. Tanabe, Hoda Tawfik
Publikováno v:
Human Gene Therapy; Sep2010, Vol. 21 Issue 9, p1119-1128, 10p